FDA Drug · D-0050-2027

Heparin Sodium Injection, USP, 5,000 USP Units/mL, 1mL Multi dose vial x 25 vials per carton, Distributed by: Hepalink USA Inc., Langhome, PA 19047-1885. Carton NDC: NDC 81952-111-06, Vial NDC: 81942-111-01

Class II · Ongoing

Lack of Assurance of Sterility

Affected lots / codes — check yours against thisLot# CU03232A, Exp 1/31/2028

Recalling firm: Shenzhen Techdow Pharmaceutical Co., Ltd., Shenzhen,
Classification: Class II (temporary or reversible harm possible)
Status: Ongoing
Quantity: 251,000 1 mL multidose vials
Distribution: Nationwide in the USA.
Recall initiated: October 1, 2026
Classified: October 16, 2026
Initiation: Voluntary: Firm initiated

Official source. This record is published by the U.S. FDA through the openFDA enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0050-2027%22

Important. Recalls target specific lots and codes — compare the affected lots above against your own product. This page reproduces public FDA data for readability; EveryRecall is independent and not affiliated with the FDA.

Check this brand across all 8 databases →